This Prospective Observational Study Aims to Evaluate the Capability of Ultra-high-resolution Photon-counting CT Angiography (UHR PCD-CTA) for Noninvasive Evaluation of Intracranial Venous Sinus Stents. The Study Will Compare Image Quality, Stent Visualization, Metal-related Artifacts, and Diagnosti
Evaluation of Ultra-High-Resolution Photon-Counting CT Angiography for Intracranial Venous Sinus Stent Assessment
1 other identifier
observational
200
1 country
1
Brief Summary
This prospective observational study aims to evaluate the effectiveness of ultra-high-resolution photon-counting CT angiography (UHR PCD-CTA) for noninvasive assessment of intracranial venous sinus stents. The study will compare image quality, stent visualization, metal-related artifacts, and diagnostic accuracy between PCD-CTA and conventional energy-integrating detector CT angiography (EID-CTA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2026
CompletedFirst Submitted
Initial submission to the registry
August 8, 2026
CompletedFirst Posted
Study publicly available on registry
August 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 7, 2029
August 20, 2026
August 1, 2026
3 years
August 8, 2026
August 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement between UHR PCD-CTA and DSA for intracranial venous sinus stent patency
Agreement between ultra-high-resolution photon-counting detector CT angiography (UHR PCD-CTA) and digital subtraction angiography (DSA) for the assessment of intracranial venous sinus stent patency will be quantified using Cohen's kappa (κ) coefficient. Stent patency will be classified according to the predefined diagnostic criteria, with DSA serving as the reference standard.
1-4 years
Secondary Outcomes (1)
Signal-to-noise ratio on UHR PCD-CTA
1-4years
Study Arms (1)
Patients With Intracranial Venous Sinus Stenosis
Patients with symptomatic intracranial venous sinus stenosis who underwent CT angiography before and after venous sinus stent implantation.
Eligibility Criteria
Patients with symptomatic intracranial venous sinus stenosis
You may qualify if:
- Adults aged ≥18 years.
- History of intracranial venous sinus stent implantation.
- Undergoing follow-up contrast-enhanced CT angiography after stent -placement.
- Available clinical and imaging data.
You may not qualify if:
- Severe motion artifacts affecting image interpretation.
- Contraindication to iodinated contrast media.
- Severe renal impairment preventing contrast-enhanced CT examination.
- Incomplete imaging data.
- Other conditions preventing reliable assessment of the venous sinus stent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xin Loulead
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
Study Officials
- STUDY CHAIR
Xin Lou
Chinese PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chairman
Study Record Dates
First Submitted
August 8, 2026
First Posted
August 13, 2026
Study Start
January 7, 2026
Primary Completion (Estimated)
January 7, 2029
Study Completion (Estimated)
January 7, 2029
Last Updated
August 20, 2026
Record last verified: 2026-08